logo

For the Inventor, By the Inventor

Berkeley, CA, United States of America

Xoma Technology Ltd.


USPTO Granted Patents = 84

% Expired Patents = 25.0



Forward Citations = 633

Loading Chart...
Loading Chart...

82 inventors (with patents filed for the assignee):

goldMedal Arnold H Horwitz (22 out of 49 patents)

silverMedal Linda Masat (17 out of 20 patents)

bronzeMedal Marina Roell (13 out of 18 patents)

4.  Daniel H Bedinger (11 out of 16 patents)

5.  Amer M Mirza (11 out of 16 patents)

6.  Mary Haak-Frendscho (10 out of 47 patents)

7.  Roger G Little, Ii (10 out of 36 patents)

8.  Gang Chen (10 out of 57 patents)

9.  Toshihiko Takeuchi (8 out of 22 patents)

10.  Patrick J Scannon (7 out of 30 patents)

11.  Alan M Solinger (7 out of 10 patents)

12.  Marc D Better (7 out of 29 patents)

13.  Shireen S Khan (6 out of 9 patents)

14.  Ajay J Narasimha (6 out of 6 patents)

15.  Robert Bauer (6 out of 6 patents)


Core Competencies:
TGF-Beta Inhibitors
PD-1 Antibodies
Monoclonal Antibodies
Cancer Treatment
Immune Modulation
Antibody Production
Tumor Microenvironment
Biologics
Therapeutic Peptides
Antibody Fragments
Recombinant Proteins
Antimicrobial Agents

84 patents:

1. 12071475 - Antibodies that bind transforming growth factor beta (TGF beta) and methods of use thereof for treatment (2024-08-27),
2. 11685775 - Method of increasing the ratio of effector T cells to regulatory T cells in a tumor by administering to a subject a TGF-beta inhibitor and a PD-1 antibody (2023-06-27),
3. 11098111 - Method of treating cancer by administering an antibody that binds transforming growth factor beta (TGF-beta) 1, TGF-beta 2 and TGF-beta 3 (2021-08-24),
4. 11034759 - Humanized M-CSF specific monoclonal antibodies, kits, and uses thereof (2021-06-15),
5. 10683347 - Treatment of cancer using anti-TGF-β and anti-PD-1 antibodies (2020-06-16),
6. 10358486 - Nucleic acids encoding, and methods of producing, antibodies specific for transforming growth factor (TGF)-β (2019-07-23),
7. 10167334 - Treatment of cancer using anti-TGF-BETA and PD-1 antibodies (2019-01-01),
8. 9926371 - M-CSF specific monoclonal antibody and uses thereof (2018-03-27),
9. 9885711 - Screening methods (2018-02-06),
10. 9732143 - Methods and materials for enhancing functional protein expression in bacteria (2017-08-15),
11. 9714285 - TGF-beta-specific antibodies and methods of use thereof for treatment (2017-07-25),
12. 9541004 - Antagonist antibodies against EphB3 (2017-01-10),
13. 9522186 - M-CSF specific monoclonal antibody and uses therof (2016-12-20),
14. 9145458 - Antibodies specific for TGF-β and methods of treatment thereof (2015-09-29),
15. 9102711 - Methods and materials for targeted mutagenesis (2015-08-11),
XOMA TECHNOLOGY LTD. is a technology company that specializes in software development and IT consulting services. With expertise in various domains including web and mobile applications, cloud computing, and artificial intelligence, XOMA delivers innovative solutions to clients worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

84 Patents

#6 in Berkeley, CA

#1,021 in California

#4,420 in US

#9,039 in the World

Berkeley, CA (US)
Berkeley, CA, United States of America

Xoma Technology Ltd.

Forward Citations = 633

82 inventors:

goldMedal Arnold H Horwitz (22 out of 49 patents)

silverMedal Linda Masat (17 out of 20 patents)

bronzeMedal Marina Roell (13 out of 18 patents)

4.  Daniel H Bedinger (11 out of 16 patents)

5.  Amer M Mirza (11 out of 16 patents)

Please report any incorrect information to [email protected]
Loading…